Company intelligence / Profile preview
Vitti Labs
Liberty, Missouri, United Statesvittilabs.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Vitti Labs is conducting Phase II clinical trials for treatments involving mesenchymal stem cells and exosomes, particularly for pulmonary fibrosis secondary to COVID-19 and ARDS associated with COVID-19.
- Therapeutic areas
- PulmonologyPsychiatryInfectious Diseases
- Modalities
- Mesenchymal Stem CellsExosomesHuman Cellular and Tissue-based Products (HCT/Ps)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Beyond the preview
Go deeper on Vitti Labs.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vitti Labs.